Diabetes Outcomes in COVID-19 Pandemic

NCT04573335 | Completed

• 1 other identifier: 16102019
• Study Type: observational
• Target: 1,282
• Locations: 1 country
• Sites: 1

Brief Summary

Diabetes management and follow-up has become a challenge during the COVID-19 pandemic. Nation-wide lockdowns and social distancing measures adopted in an attempt to break the chain of COVID-19 transmission have significantly disrupted routine care and follow-up of diabetes. In the health sector, especially in low-income countries such as Pakistan, there has been a shift of resources and staff reassignment from stable chronic illnesses to support COVID-19 pandemic. Disruption of routine outpatient health services and travel restrictions increase the risk of worsening diabetes control and diabetes-related health outcomes. Additionally, social isolation amidst an atmosphere of fear and uncertainty contributes to stress further affecting glycaemic control.

Conditions

Diabetes; Covid19; Isolation, Social

Keywords

COVID-19; diabetes mellitus; telesurvey

Outcome Measures

Primary Outcomes (1)

• All-cause mortality

  Death due to diabetes-related complications or otherwise

  during 3months of lockdown

Secondary Outcomes (1)

• COVID-19 illness

  During 3months of lockdown

Eligibility Criteria

• Age: 18 Years - 70 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Diabetic subjects already registered with and on regular follow-up with DMC and had visited DMC for consultation more than once between 1st August 2019 to 15th March 2020.

You may qualify if:

• Type 1 and type 2 diabetic patients registered with Diabetes Management Centre, Services hospital, Lahore, Pakistan.

You may not qualify if:

• Patients lacking telephonic contact or with invalid contact numbers.

Sponsors & Collaborators

• Services Institute of Medical Sciences, Pakistan: lead

Study Sites (1)

Services Hospital

Lahore, Punjab Province, 540000, Pakistan

Location

MeSH Terms

Conditions

Diabetes Mellitus; COVID-19; Social Isolation

Condition Hierarchy (Ancestors)

Glucose Metabolism Disorders; Metabolic Diseases; Nutritional and Metabolic Diseases; Endocrine System Diseases; Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases; Social Behavior; Behavior

Study Officials

• Saira Burney, MB;FRCP (Edin)

  SIMS

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER GOV
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Doctor

Study Record Dates

• First Submitted: September 29, 2020
• First Posted: October 5, 2020
• Study Start: June 1, 2020
• Primary Completion: July 15, 2020
• Study Completion: July 30, 2020
• Last Updated: October 5, 2020

Record last verified: 2020-09

Data Sharing

• IPD Sharing: Will not share

Locations

PA (1)